Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Tzanakos

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Molecular Genetics and Metabolism|January 22, 2015
An audit of newborn screening procedure: impact on infants presenting clinically before results are availableGalit Tal, James Pitt, Sally Morrisy, et al.
JIMD Reports|February 25, 2014
4-hydroxyglutamate is a biomarker for primary hyperoxaluria type 3James J Pitt, Frank Willis, Nicholas Tzanakos, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Molecular Genetics and Metabolism|January 22, 2015
An audit of newborn screening procedure: impact on infants presenting clinically before results are availableGalit Tal, James Pitt, Sally Morrisy, et al.
JIMD Reports|February 25, 2014
4-hydroxyglutamate is a biomarker for primary hyperoxaluria type 3James J Pitt, Frank Willis, Nicholas Tzanakos, et al.
Pageof 1